Shuai Li
Qiqihar University(CN)Union Hospital(CN)Shanxi University(CN)Dalian Medical University(CN)Dalian University of Technology(CN)Bioscience Research(US)Shanghai CASB Biotechnology (China)(CN)Dalian Municipal Central Hospital(CN)Chengde Medical University(CN)First Affiliated Hospital of Dalian Medical University(CN)Huazhong University of Science and Technology(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, MicroRNA in disease regulation, Autophagy in Disease and Therapy, RNA modifications and cancer, Circular RNAs in diseases
Most-Cited Works
- → Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids(2017)559 cited
- → The KRASG12C Inhibitor MRTX849 Reconditions the Tumor Immune Microenvironment and Sensitizes Tumors to Checkpoint Inhibitor Therapy(2021)161 cited
- → MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells(2010)145 cited
- → Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression(2017)140 cited
- → Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization(2021)101 cited
- → TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling(2016)74 cited